![[trans-4-[(tert-Butoxycarbonyl)amino]cyclohexyl]methyl 4-methylbenzenesulfonate chemical structure](/media/structures/QKORMZDTAQDQQF-UHFFFAOYSA-N.svg)
[trans-4-[(tert-Butoxycarbonyl)amino]cyclohexyl]methyl 4-methylbenzenesulfonate
- CAS
- 947141-76-6
- Formula
- C19H29NO5S
- MW
- 383.5 g/mol
VQ-049287
Impurity reference standards
Oclacitinib impurities & reference standards
Characterised Oclacitinib impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
9reference materials
1isotope-labelled
COAHPLC · NMR · MS on request
![cis-N-Methyl-4-(methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide chemical structure](/media/structures/XQVKMZLSAJZMNW-UHFFFAOYSA-N.svg)
cis-N-Methyl-4-(methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide
- CAS
- 1538596-97-2
- Formula
- C30H46N10O4S2
- MW
- 674.9 g/mol
VQ-038714
![Rel-((1r,4r)-4-(Methyl(7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methyl 4-methylbenzenesulfonate chemical structure](/media/structures/JHUZBBKFDQCQAF-UHFFFAOYSA-N.svg)
Rel-((1r,4r)-4-(Methyl(7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methyl 4-methylbenzenesulfonate
- CAS
- 1208319-32-7
- Formula
- C28H32N4O5S2
- MW
- 568.7 g/mol
VQ-049286
![trans-4-[Methyl[7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]cyclohexanemethanol chemical structure](/media/structures/OVKOFWBZMNJHNG-UHFFFAOYSA-N.svg)
trans-4-[Methyl[7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]cyclohexanemethanol
- CAS
- 2538954-26-4
- Formula
- C21H26N4O3S
- MW
- 414.5 g/mol
VQ-049285
![trans-N,N-Dimethyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide chemical structure](/media/structures/LHULOQNZKNAHGE-UHFFFAOYSA-N.svg)
trans-N,N-Dimethyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide
- CAS
- 1312034-35-7
- Formula
- C16H25N5O2S
- MW
- 351.5 g/mol
VQ-038712
FAQs — Oclacitinib impurities
Which Oclacitinib impurities do you supply?
We list 9 Oclacitinib-related reference materials, including process impurities, degradation products, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Oclacitinib impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Oclacitinib impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Oclacitinib impurity standards
We reply within one business day with price, pack options, lead time and documentation.